Cantrell recalls drugs over sterility issues: 4 things to know

Cantrell Drug Co. issued a voluntary recall of all lots of its unexpired sterile drug products due to a lack of sterility assurance.

Here are four things to know.

1. The recalled syringes and IV bags were distributed to healthcare facilities across the country between Feb. 16 and July 19.

2. The national recall excludes four states that did not receive any drug shipments from Cantrell: Connecticut, Hawaii, South Carolina and Vermont.

3. Administration of unsterile drugs could result in serious, even life-threatening infections, according to a Food and Drug Administration recall safety alert.

4. Cantrell is notifying customers of the recall and working with them to arrange the return of affected products.

More articles on supply chain:

How Dems' 'Better Deal' would address drug costs: 3 notes
FDA approves Lupin's generic skin cream
Supply chain leaders worried about potential market entry of Amazon

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars